Upsher-Smith Laboratories, LLC is a trusted U.S.
pharmaceutical company striving to improve the health and lives of patients
through an unwavering commitment to high-quality generic and branded products
and sustainable growth.
Upsher-Smith Laboratories, LLC is a fully integrated pharmaceutical company focused on commercialization of prescription pharmaceutical products in the U.S. market. With our diverse portfolio of high-quality products, we strive to improve the health and lives of patients. In 2019 we celebrate our centennial anniversary and enter a new ambitious era accelerated by our 2017 acquisition by Osaka, Japan-based Sawai Pharmaceutical Co., Ltd.
Over the past 100 years we have offered a broad array of generics serving a wide span of disease states and conditions. In addition, we’ve built a commercial infrastructure focused on the epilepsy and migraine segments that has resulted in the addition of Qudexy® XR (topiramate extended-release capsules), Vigadrone® (vigabatrin powder for oral solution), Tosymra™ (sumatriptan nasal spray) and Zembrace® SymTouch® (sumatriptan injection) to our branded product portfolio. Our drugs are delivered to a variety of customers, always backed by an attentive level of service, strong industry relationships, and a dedication to uninterrupted supply.
Upsher-Smith is currently seeking partners with a solid history of success and a vision for future growth and innovation, who can help us expand both our brand and generic portfolios. We are specifically interested in opportunities to acquire, license or co-develop:
- Diverse dosage-form generic products, including ophthalmics and injectables
- Differentiated 505b2 products in the epilepsy and migraine categories
- Late-stage assets, both brands and generics
Together, we seek to deliver the best value for our mutual stakeholders, and most importantly, to do more good for the patients we serve. For more information, visit www.upsher-smith.com.
|Affiliated categories:||Finished Dosage Forms |Out-licensing |Sprays More|
Our Top products
Tosymra™ is an FDA-approved, nasal spray formulation of sumatriptan utilizing Intravail™ technology as a permeation enhancer, resulting in more complete and rapid absorption of sumatriptan as compared to other nasal formulations.More info
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation